Table 2 Clinical and pathological characters of 273 Tibetan female with BC
Clinical characters | |
|---|---|
Tumor size | |
≤ 2 cm (n, %) | 19(7.0) |
>2 cm (n, %) | 228(83.5) |
Unknown (n, %) | 26(9.5) |
Total (n, %) | 273(100.0) |
T4 stage | |
Skin invasion only (n, %) | 64(23.4) |
Chest invasion only (n, %) | 6(2.2) |
Skin and Chest invasion (n, %) | 6(2.2) |
- (n, %) | 169(61.9) |
Unknown (n, %) | 28(10.3) |
Total (n, %) | 273(100.0) |
Pathologic characters | |
Pathologic type | |
Ductal carcinoma in situ (n, %) | 3(1.1) |
Invasive carcinoma, Nos (n, %) | 220(80.6) |
Invasive carcinoma, special type (n, %) | 25(9.1) |
Invasive carcinoma, untyped | 13(4.8) |
BC, untyped | 12(4.4) |
Total (n, %) | 273(100.0) |
Pathologic grade | |
Ductal carcinoma in situ | |
High grade (n, %) | 3(1.1) |
Middle/Low grade (n, %) | 0(0) |
Invasive carcinoma, NOS | |
I (n, %) | 23(8.4) |
II (n, %) | 102(37.4) |
III (n, %) | 95(34.8) |
Ungraded of invasive carcinoma, special type or untyped (n, %) | 38(13.9) |
Unknown (n, %) | 12(4.4) |
Total (n, %) | 273(100.0) |
LNM | |
N1 (n, %) | 57(20.9) |
N2 (n, %) | 80(29.3) |
N3 (n, %) | 38(13.9) |
N0 (n, %) | 61(22.3) |
Unknown (n, %) | 37(13.6) |
Total (n, %) | 273(100.0) |
AJCC stage | |
0 (n,%) | 3 (1.1) |
I(n,%) | 3(1.1) |
II (n, %) | 78(28.6) |
III (n, %) | 138(50.5) |
IV (n, %) | 16(5.9) |
Unknown (n, %) | 35(12.8) |
Total (n, %) | 273(100.0) |